Abiopharma

NASDAQ traded attribute type Security_Name was changed. Previous value: Indivior PLC - Ordinary Shares. New value: Indivior Pharmaceuticals, Inc. - Common Stock.

FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review

Legend Biotech (LEGN) Files Form 6-K

OKYO Pharma (OKYO) Files Form 6-K

Cardiol Therapeutics Inc (CRDL) Files Form 6-K

Smith & Nephew SNATS Inc (SNN) Files Form 6-K

ENLIVEX (ENLV) Files Form 6-K

Adagene Inc. (ADAG) Files Form 6-K

Integer Holdings Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Integer Holdings Corporation - ITGR

FONAR Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FONAR Corporation - FONR

Charlottes Web Commends Representative Griffith for Leadership Introducing Hemp Enforcement, Modernization, and Protection (HEMP) Act

New Form SCHEDULE 13D/A - IO Biotech, Inc. Filed: 2026-01-23 AccNo: 0001388325-26-000003 Size: 32 KB

New Form SCHEDULE 13G - BriaCell Therapeutics Corp. Filed: 2026-01-23 AccNo: 0001104659-26-006332 Size: 27 KB

ResMed Inc. Daily Stock Update

New Form 4/A - P3 Health Partners Inc. Filed: 2026-01-23 AccNo: 0001232914-26-000002 Size: 5 KB